Skip to content

Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (MGAT4A)

Homo sapiens — UniProt Q9UM21

Gene: MGAT4AHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (MGAT4A) is a protein from Homo sapiens identified by UniProt accession Q9UM21, 535 residues long. MolForge cross-references it against 0 known binders and 126 disease associations.

  • UniProt accession: Q9UM21; gene symbol MGAT4A.
  • Organism: Homo sapiens.
  • Length: 535 amino acids.
  • Top disease associations (Open Targets): COVID-19, metastatic colorectal cancer and response to cetuximab.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameAlpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
UniProt accessionQ9UM21
GeneMGAT4A
OrganismHomo sapiens
Length535 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (126)

Diseases linked to this target (Open Targets).

  • COVID-19 · score 0.37
  • metastatic colorectal cancer · score 0.28
  • response to cetuximab · score 0.28
  • response to CAPOX-B · score 0.28
  • progression free survival · score 0.28
  • eosinophil count · score 0.07
  • MODY · score 0.06
  • hepatitis C virus infection · score 0.06
  • glycogen storage disease VI · score 0.06
  • hypoinsulinemic hypoglycemia and body hemihypertrophy · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UM21-F1alphafoldPREDICTED85.22—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UM21.

Amino-acid sequence (535 residues)

MRLRNGTVAT ALAFITSFLT LSWYTTWQNG KEKLIAYQRE FLALKERLRI AEHRISQRSS ELNTIVQQFK RVGAETNGSK DALNKFSDNT LKLLKELTSK KSLQVPSIYY HLPHLLKNEG SLQPAVQIGN GRTGVSIVMG IPTVKREVKS YLIETLHSLI DNLYPEEKLD CVIVVFIGET DIDYVHGVVA NLEKEFSKEI SSGLVEVISP PESYYPDLTN LKETFGDSKE RVRWRTKQNL DYCFLMMYAQ EKGIYYIQLE DDIIVKQNYF NTIKNFALQL SSEEWMILEF SQLGFIGKMF QAPDLTLIVE FIFMFYKEKP IDWLLDHILW VKVCNPEKDA KHCDRQKANL RIRFRPSLFQ HVGLHSSLSG KIQKLTDKDY MKPLLLKIHV NPPAEVSTSL KVYQGHTLEK TYMGEDFFWA ITPIAGDYIL FKFDKPVNVE SYLFHSGNQE HPGDILLNTT VEVLPFKSEG LEISKETKDK RLEDGYFRIG KFENGVAEGM VDPSLNPISA FRLSVIQNSA VWAILNEIHI KKATN

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with MGAT4A?

The strongest Open Targets associations for MGAT4A are COVID-19, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B and progression free survival.

How long is the MGAT4A protein?

The Homo sapiens MGAT4A protein (UniProt Q9UM21) is 535 amino acids long.

Browse: Targets: M · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UM21
GeneMGAT4A
OrganismHomo sapiens
Length535
Binders0
Diseases126
View on UniProt